Medicines regulator National Drug Authority (NDA) has explained its decision to block the production and distribution of Covid19 herbal drug Covilyce 1.
Gulu University scientists claim they have tested Covilyce 1 on over 100 Covid19 patients, with good results.
The drug, that comes in nasal drops, linctus, suppositories and powder forms, heals Covid19 within a period of between 12 and 72 hours.
The university had also revealed it would continue to conduct trials of the drug, which they said would be administered and distributed by its team of trained herbalists.
But NDA has confirmed blocking the production, and distribution of Covilyce 1 pending approval.
“NDA has not approved this product, it shouldn’t be on the market and the innovators have been warned,” said the medicines regulator.
“They confirmed this product is still under lab research and tests. Before we notify a product, it shouldn’t be used as we can’t guarantee it’s safety.”
By Dr. Julius Babyetsiza There are many ways to define a business model. Simply put,…
Prof Kithure Kindiki aka Abra K has been sworn in as Kenya’s third vice president…
Ugandan journalist Blanshe Musinguzi is this year’s African Investigative Journalist of the Year Award winner.…
Botswana President Mokgweetsi Masisi has conceded defeat in the country’s general election, and promised to…
As he continues to argue for the rationalization of 'parasitic' agencies, President Yoweri Museveni has…
Uganda Registration Services Bureau (URSB) Registrar General Mercy Kainobwisho has spoken out after what is…